Literature DB >> 25669948

[Movement disorders in anti-N-NMDA receptor encephalitis].

E H C W van de Riet, S C van Bronswijk, J N M Schieveld.   

Abstract

BACKGROUND: Anti-N-methyl-D-aspartate receptor encephalitis (anmdare) is a serious disease, that has only been known since 2007; movement disorders form part of the neuropsychiatric symptomatology. AIM: To provide an overview of movement disorders in anmdare and to emphasise the complexity of this disease with regard to diagnostics and treatment.
METHOD: We searched the literature using PubMed, Medline and Cochrane and the search terms 'Anti-N-Methyl-D-Aspartate Receptor Encephalitis' OR 'anti-nmda receptor encephalitis' OR 'anti-nmdar encephalitis' AND 'movement disorders' OR 'catatonia'.
RESULTS: Orofacial dyskinesia is the most characteristic movement disorder in anmdare. Dyskinesia was observed in 80% of the patients; young children (<12 years old) have movement disorders more often.
CONCLUSION: Movement disorders are typical but aspecific symptoms of anmdare. More than one movement disorder is present in nearly all cases, a factor that can make early diagnosis difficult and can delay the start of appropriate treatment.

Entities:  

Mesh:

Year:  2015        PMID: 25669948

Source DB:  PubMed          Journal:  Tijdschr Psychiatr        ISSN: 0303-7339


  2 in total

1.  Bilateral thalamic changes in anti-NMDAR encephalitis presenting with hemichorea and dystonia and acute transient psychotic disorder.

Authors:  Souvik Dubey; Ritwik Ghosh; Mahua Jana Dubey; Samya Sengupta; Julián Benito-León; Biman Kanti Ray
Journal:  J Neuroimmunol       Date:  2020-07-22       Impact factor: 3.478

2.  Risk factors for pneumonia in patients with anti-NMDA receptor encephalitis: A single-center retrospective study.

Authors:  Xiaohui Miao; Pingqiao Yuan; Lihong Zhao; Le Zhang; Xinyue Jiang; Hanyu Cao; Hongrui Shi; Jinmei Li; Rong Yang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.